HLA genotyping - relevant not only in donor-patient matching
In 2019, DKMS started to inform potential donors about certain results of their HLA typing, as these are of great medical importance in some medical circumstances. In particular, knowledge of the HLA allele B*58:01 could prevent serious adverse reactions to a commonly prescribed drug worldwide.
An updated version of this page is available.